A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy-Reference-Cited by-同舟云学术

A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy

Published:2023-10-01 Issue:10 Volume:56 Page:547-559
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

Author:

Tai Yuta¹,Morita Yoshifumi²,Makino Mitsumasa²,Ida Shinya²,Muraki Ryuta²,Kitajima Ryo²,Takeda Makoto²,Kikuchi Hirotoshi²,Hiramatsu Yoshihiro²,Takeuchi Hiroya²

Affiliation:

1. Department of Surgery, Shizuoka City Shimizu Hospital

2. Department of Surgery, Hamamatsu University School of Medicine

Publisher

The Japanese Journal of Gastroenterological Surgery

Subject

Gastroenterology,Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/56/10/56_2022.0104/_pdf

Reference37 articles.

1. 1) Zhang Y, Huang G, Wang Y, Liang L, Peng B, Fan W, et al. Is salvage liver resection necessary for initially unresectable hepatocellular carcinoma patients downstaged by transarterial chemoembolization? Ten years of experience. Oncologist. 2016;21:1442–1449.

2. 2) Yoshimoto T, Imura S, Morine Y, Ikemoto T, Arakawa Y, Iwahashi S. et al. The outcome of sorafenib therapy on unresectable hepatocellular carcinoma: experience of conversion and salvage hepatectomy. Anticancer Res. 2018 Jan;38(1):501–507.

3. 3) Sho T, Morikawa K, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, et al. Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy. World J Gastrointest Oncol. 2021 Dec;13(12):2076–2087.

4. 4) Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163–1173.

5. 5) Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226:688–701.